Brief: Getinge Granted U.S. FDA 510(K) Clearance For Its Innovative Clinical Decision Support Software Talis +Acg
12/06/2024 14:10
June 12 (Reuters) - Getinge AB GETIb.ST :
* GETINGE: GRANTED U.S. FDA 510(K) CLEARANCE FOR ITS
INNOVATIVE
CLINICAL DECISION SUPPORT SOFTWARE TALIS +ACG
Source text for Eikon: ID:
Further company coverage: GETIb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsBrief: CEO Buys SEK 4.7 Million Of Getinge Shares
Johnson & Johnson defeats heart-pump patent claims in US trial (updated)
Johnson & Johnson defeats heart-pump patent claims in US trial
Brief: Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S.
Getinge lags profit estimates as uncertainty curbs investments in medical equipment